Innoviva (INVA) Revenue (2011 - 2026)
Innoviva posted quarterly Revenue of $98.0 million for Q1 2026, up 10.56% year-on-year from $88.6 million in Q1 2025, and up 8931.71% on a QoQ basis from $1.1 million in Q4 2025.
Innoviva (INVA) has 16 years of Revenue data on file, last reported at $98.0 million in Q1 2026.
- For the quarter ending Q1 2026, Revenue rose 10.56% year-over-year to $98.0 million; the trailing twelve-month figure through Mar 2026 stood at $307.2 million (up 9.99% YoY), and the FY2025 full-year result was $411.3 million, up 14.67% from the prior year.
- Revenue for Q1 2026 stood at $98.0 million, up from $1.1 million in the prior quarter.
- Across five years, Revenue topped out at $107.8 million in Q3 2025 and bottomed at $796000.0 in Q1 2023.
- The 5-year median for Revenue is $1.5 million (2023), against an average of $39.0 million.
- The widest annual swing landed in 2022, when Revenue sank 98.67%; it then jumped 10093.67% in 2024.
- A 5-year view of Revenue shows it stood at $1.1 million in 2022, then surged by 45.39% to $1.5 million in 2023, then dropped by 19.18% to $1.2 million in 2024, then slipped by 12.15% to $1.1 million in 2025, then jumped by 8931.71% to $98.0 million in 2026.
- The last three Revenue figures came in at $98.0 million (Q1 2026), $1.1 million (Q4 2025), and $107.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 97.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 97.99 Mn |
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | 107.80 Mn |
| Jun 30, 2025 | 100.28 Mn |
| Mar 31, 2025 | 88.63 Mn |
| Dec 31, 2024 | 1.24 Mn |
| Sep 30, 2024 | 89.51 Mn |
| Jun 30, 2024 | 99.90 Mn |
| Mar 31, 2024 | 966,000.00 |
| Dec 31, 2023 | 1.53 Mn |
| Sep 30, 2023 | 67.26 Mn |
| Jun 30, 2023 | 980,000.00 |
| Mar 31, 2023 | 796,000.00 |
| Dec 31, 2022 | 1.05 Mn |
| Sep 30, 2022 | 1.30 Mn |
| Jun 30, 2022 | 1.88 Mn |
| Mar 31, 2022 | 1.24 Mn |
| Dec 31, 2021 | 989,000.00 |
| Sep 30, 2021 | 97.86 Mn |
| Jun 30, 2021 | 1.17 Mn |
| Mar 31, 2021 | 1.07 Mn |
| Dec 31, 2020 | 504,000.00 |
| Sep 30, 2020 | 88.69 Mn |
| Jun 30, 2020 | 78.95 Mn |
| Mar 31, 2020 | 78.68 Mn |
| Dec 31, 2019 | 75.97 Mn |
| Sep 30, 2019 | 65.76 Mn |
| Jun 30, 2019 | 64.11 Mn |
| Mar 31, 2019 | 55.18 Mn |
| Dec 31, 2018 | 79.86 Mn |
| Sep 30, 2018 | 61.68 Mn |
| Jun 30, 2018 | 67.09 Mn |
| Mar 31, 2018 | 52.38 Mn |
| Dec 31, 2017 | 69.52 Mn |
| Sep 30, 2017 | 48.64 Mn |
| Jun 30, 2017 | 58.56 Mn |
| Mar 31, 2017 | 40.49 Mn |
| Dec 31, 2016 | 43.61 Mn |
| Sep 30, 2016 | 33.31 Mn |
| Jun 30, 2016 | 32.47 Mn |
| Mar 31, 2016 | 24.18 Mn |
| Dec 31, 2015 | 22.84 Mn |
| Sep 30, 2015 | 13.56 Mn |
| Jun 30, 2015 | 10.66 Mn |
| Mar 31, 2015 | 6.90 Mn |
| Dec 31, 2014 | 7.28 Mn |
| Sep 30, 2014 | 999,000.00 |
| Jun 30, 2014 | 934,000.00 |
| Mar 31, 2014 | 780,000.00 |
| Dec 31, 2013 | 1.47 Mn |
| Sep 30, 2013 | 415,000.00 |
| Jun 30, 2013 | 1.32 Mn |
| Mar 31, 2013 | 1.32 Mn |
| Dec 31, 2012 | -124.35 Mn |
| Sep 30, 2012 | 1.43 Mn |
| Jun 30, 2012 | 523,000.00 |
| Mar 31, 2012 | 125.80 Mn |
| Dec 31, 2011 | 5.36 Mn |
| Sep 30, 2011 | 6.43 Mn |
| Jun 30, 2011 | 6.39 Mn |
| Mar 31, 2011 | 6.33 Mn |